Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances KREF Q1 2026 Earnings Deep EPS Miss Masks Underlying Stability ATLCZ Q1 2026 Earnings Strong EPS Beat Highlights Solid Operational Performance BXP Q1 2026 Earnings Strong EPS Surprise Driven by Operational Efficiency Dyadic International Inc DYAI Q1 2026 Earnings EPS Misses Estimates as PreRevenue Status Continues P3 Health Partners Inc PIII Q1 2026 Earnings Surprise Profit Beats Heavy Loss Estimate Yet Stock Declines